Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Nina Thakkar-Rivera"'
Autor:
Mileydis Alonso, Radhika K. Neicheril, Yosef Manla, Malcolm L. McDonald, Alejandro Sanchez, Gabrielle Lafave, Yelenis Seijo De Armas, Antonio Lewis Camargo, Dipan Uppal, David Wolinsky, Nina Thakkar‐Rivera, Mauricio Velez, David A. Baran, Jerry D. Estep, David Snipelisky
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3649-3655 (2024)
Abstract Aims Transthyretin cardiac amyloidosis (ATTR‐CA) is most often associated with heart failure with preserved ejection fraction (HFpEF). However, patients may present with impaired systolic function at the time of diagnosis, which has not be
Externí odkaz:
https://doaj.org/article/12457931b31f4a85b2136c051a49736a
Autor:
Crystal Lihong Yan, David Snipelisky, Mauricio Velez, David Baran, Jerry D. Estep, E. Joseph Bauerlein, Nina Thakkar Rivera
Publikováno v:
American Heart Journal Plus, Vol 45, Iss , Pp 100438- (2024)
The objective of our study was to evaluate the real-world effects of an aggressive, personalized protocol for guideline-directed medical therapy (GDMT) titration in patients with heart failure (HF) with reduced ejection fraction (HFrEF). We conducted
Externí odkaz:
https://doaj.org/article/3c9a270209cc493b994aefc20351d969
Autor:
Crystal Lihong Yan, MD, MBA, Hope Hua, MD, Felipe Ruiz, MD, Jason Margolesky, MD, E. Joseph Bauerlein, MD, David Snipelisky, MD, Nina Thakkar Rivera, DO, PhD
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100078- (2024)
Prevention of acute allograft dysfunction is the principal focus in the immediate post-transplant period. However, many immune-modulating agents have been associated with posterior reversible encephalopathy syndrome (PRES). We describe a complex case
Externí odkaz:
https://doaj.org/article/e10e9213d78948ecaad1c2eae28234a2
Autor:
Dipan Uppal, MD, Ersilia M. DeFilippis, MD, Jillian Dietz, PharmD, David Baran, MD, Jerry D. Estep, MD, Mauricio Velez, MD, Nina Thakkar Rivera, DO, PhD, David Snipelisky, MD
Publikováno v:
JHLT Open, Vol 3, Iss , Pp 100023- (2024)
Externí odkaz:
https://doaj.org/article/e897fe5c5f80498882aafa0c2a8e089f
Publikováno v:
Case Reports in Cardiology, Vol 2022 (2022)
A 68-year-old female with end-stage heart failure presented to the hospital for heart transplant. She was diagnosed with achalasia 14 months prior and treated with frequent botulinum toxin injections. She underwent orthotopic heart transplant on the
Externí odkaz:
https://doaj.org/article/6d3f492a83184d1489b94bd704f8891c
Autor:
Nina Thakkar, Rivera, David A, Baran
Publikováno v:
Current Opinion in Cardiology. 38:130-135
Despite advances in the technology of mechanical circulatory support, the need for heart transplantation continues to grow. The longevity of heart transplants continues to be superior to mechanical solutions, though the short-term differences are shr
Autor:
Crystal Lihong Yan, Gaurav Gupta, Luiz Paulo Guido, Philip Ruiz, Eugene Joseph Bauerlein, Nina Thakkar Rivera
Publikováno v:
Clinical transplantation.
Autor:
Ali Ghodsizad, Shweta Anjan, Mrudula Munagala, Joseph Bauerlein, Jose F. Suarez, Jorge L. Cardenas-Alvarez, Yoichiro Natori, Nina Thakkar-Rivera, Gabriel Motoa, Joao Roberto Breda, Jacques Simkins, Anita Phancao, Matthias Loebe
Publikováno v:
Journal of Cardiac Surgery. 36:4786-4788
The use of left ventricular assist devices (LVADs) is increasingly more common as the availability of donor organs in relation to failing hearts is outstandingly limited. Infections are the most common complications in LVAD recipients, particularly t
Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices
Publikováno v:
Cardiology and therapy. 11(3)
Cardiogenic shock (CS) remains a leading cause of morbidity and mortality among patients with cardiovascular disease. In the past, acute myocardial infarction was the leading cause of CS. However, in recent years, other etiologies, such as decompensa
Publikováno v:
Emergency Medicine International, Vol 2016 (2016)
The American Heart Association reports the annual incidence of out-of-hospital cardiopulmonary arrests (OHCA) is greater than 300,000 with a survival rate of 9.5%. Bystander cardiopulmonary resuscitation (CPR) saves one life for every 30, with a 10%
Externí odkaz:
https://doaj.org/article/7d3fc9cee0a140e8a0878ed75d575b94